Medtronic 2016 Annual Report Download - page 148

Download and view the complete annual report

Please find page 148 of the 2016 Medtronic annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 158

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • 71
  • 72
  • 73
  • 74
  • 75
  • 76
  • 77
  • 78
  • 79
  • 80
  • 81
  • 82
  • 83
  • 84
  • 85
  • 86
  • 87
  • 88
  • 89
  • 90
  • 91
  • 92
  • 93
  • 94
  • 95
  • 96
  • 97
  • 98
  • 99
  • 100
  • 101
  • 102
  • 103
  • 104
  • 105
  • 106
  • 107
  • 108
  • 109
  • 110
  • 111
  • 112
  • 113
  • 114
  • 115
  • 116
  • 117
  • 118
  • 119
  • 120
  • 121
  • 122
  • 123
  • 124
  • 125
  • 126
  • 127
  • 128
  • 129
  • 130
  • 131
  • 132
  • 133
  • 134
  • 135
  • 136
  • 137
  • 138
  • 139
  • 140
  • 141
  • 142
  • 143
  • 144
  • 145
  • 146
  • 147
  • 148
  • 149
  • 150
  • 151
  • 152
  • 153
  • 154
  • 155
  • 156
  • 157
  • 158

Table of Contents
145
PART IV
Item 15. Exhibits and Financial Statement Schedules
(a) 1. Financial Statement Schedules
Schedule II. Valuation and Qualifying Accounts — years ended April 29, 2016, April 24, 2015, and April 25, 2014.
All other schedules are omitted because they are not applicable or the required information is shown in the financial
statements or notes thereto.
2. Exhibits
Exhibit No. Description
2.1 Transaction Agreement, dated as of June 15, 2014, among Medtronic, Inc., Covidien plc, Medtronic
plc (formerly known as Kalani I Limited), Makani II Limited, Aviation Acquisition Co., Inc., and
Aviation Merger Sub, LLC (incorporated by reference to Exhibit 2.1 to Medtronic plc’s Amendment
No. 5 to the Registration Statement on Form S-4, filed on November 20, 2014, File No. 333-197406).
2.2 Appendix III to the Rule 2.5 Announcement (Conditions Appendix) (incorporated by reference to
Exhibit 2.2 to Medtronic, Inc.’s Current Report on Form 8-K, filed on June 16, 2014, File No.
001-07707).
2.3 Expenses Reimbursement Agreement, dated as of June 15, 2014, by and between Covidien plc and
Medtronic, Inc. (incorporated by reference to Exhibit 2.3 to Medtronic, Inc.’s Current Report on
Form 8-K, filed on June 16, 2014, File No. 001-07707).
2.4 Separation and Distribution Agreement, dated as of June 29, 2007, by and among Tyco International
Ltd., Covidien Ltd. and Tyco Electronics Ltd. (incorporated by reference to Exhibit 2.1 to Covidien
plc’s Current Report on Form 8-K, filed on July 5, 2007, File No. 001-33259).
2.5 Separation and Distribution Agreement, dated as of June 28, 2013, between Covidien plc and
Mallinckrodt plc (incorporated by reference to Exhibit 2.1 to Covidien plc’s Current Report on Form
8-K filed on July 1, 2013, File No. 001-33259).
3.1 Certificate of Incorporation of Medtronic plc (incorporated by reference to Exhibit 3.1 to Medtronic
plc’s Current Report on Form 8-K, filed on January 27, 2015, File No. 001-36820).
3.2 Amended and Restated Memorandum and Articles of Association of Medtronic plc (incorporated by
reference to Exhibit 3.1 to Medtronic plc’s Current Report on Form 8-K12B, filed on January 27,
2015, File No. 001-36820).
4.1 Form of Indenture between Medtronic, Inc. and Wells Fargo Bank, National Association
(incorporated by reference to Exhibit 4.1 to Medtronic, Inc.’s Amendment No. 2 to the Registration
Statement on Form S-4, filed on January 10, 2005, File No. 333-121239).
4.2 Indenture, dated as of September 15, 2005, between Medtronic, Inc. and Wells Fargo Bank, N. A.
(including the Forms of Notes thereof) (incorporated by reference to Exhibit 4.1 to Medtronic, Inc.’s
Registration Statement on Form S-4, filed December 6, 2005, File No. 333-130163).
4.3 First Supplemental Indenture, dated as of January 26, 2015, by and among Medtronic plc, Medtronic,
Inc., Medtronic Global Holdings S.C.A. and Wells Fargo Bank, National Association (incorporated
by reference to Exhibit 4.1 to Medtronic plc’s Current Report on Form 8-K12B, filed on January 27,
2015, File No. 001-36820).
4.4 Form of Indenture between Medtronic, Inc. and Wells Fargo Bank, National Association regarding
2009 offering (incorporated by reference to Exhibit 4.1 to Medtronic, Inc.’s Registration Statement
on Form S-3, filed on March 9, 2009, File No. 333-157777).
4.5 First Supplemental Indenture, dated March 12, 2009, between Medtronic, Inc. and Wells Fargo Bank,
National Association (including the Forms of Notes thereof) (incorporated by reference to Exhibit 4.1
to Medtronic, Inc.’s Current Report on Form 8-K, filed on March 12, 2009, File No. 001-07707).
4.6 Second Supplemental Indenture, dated March 16, 2010, between Medtronic, Inc. and Wells Fargo
Bank, National Association (including the Forms of Notes thereof) (incorporated by reference to
Exhibit 4.1 to Medtronic, Inc.’s Current Report on Form 8-K, filed on March 16, 2010, File No.
001-07707).